ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1854

The Utility of Fat Lesions in Close Relation to Other Structural MRI Lesions in the Sacroiliac Joints for Diagnosing Patients with Axial Spondyloarthritis

Sengül Seven1, Mikkel Østergaard 2, Lone Morsel-Carlsen 3, inge Juul Sørensen 1, Birthe Bonde 4, Gorm Thamsborg 5, Jens Jørgen Lykkegaard 1, Oliver Hendricks 6, Niklas Rye Jørgensen 7 and Susanne Juhl Pedersen 8, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, Glostrup, Denmark, 2Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark, 3Department of Radiology, Rigshospitalet, Glostrup, Denmark, Glostrup, Denmark, 4The Birthe Bonde Clinic of Physioterapy, Copenhagen, Denmark, Glostrup, Denmark, 5Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, Copenhagen, Hovedstaden, Denmark, 6Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark, Sønderborg, Denmark, 7Department of Clinical Biochemistry, Rigshospitalet, Glostrup, Denmark, Glostrup, Denmark, 8Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, Copenhagen, Hovedstaden, Denmark

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: axial spondyloarthritis, differential diagnosis, Magnetic resonance imaging (MRI), sacroiliac joints and inflammation

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: 4M111: Imaging of Rheumatic Diseases I (1854–1859)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Bone marrow edema on MRI of the sacroiliac joints (SIJ) plays an important role in the ASAS (Assessment of Spondyloarthritis International Society) classification criteria for axial spondyloarthritis (axSpA). However, these lesions can also be seen in other conditions1 2. Structural SIJ MRI lesion characteristics may be of importance for differentiating patients with axSpA from other diagnostic entities with buttock/pelvic pain. The aim of this study was to investigate the diagnostic utility of the presence of fat lesions (FAT) in close relation to the joint space and other structural MRI lesions in order to differentiate patients with axSpA from other conditions.

Methods: This prospective cross-sectional study of 204 participants, included patients with axSpA (n=41), lumbar disc herniation (n=25), and women with postpartum buttock/pelvic pain (n=46) and a group of healthy participants consisting of women without postpartum buttock/pelvic pain (n=14), persons with hard physical work defined as hospital cleaning staff (n=26), long-distance runners (n=23) and healthy men (n=29). Participants with pain should all have VAS pain >2 (0-10) for ≥2 months. Non-axSpA participants were not allowed to have any clinical SpA features or rheumatological conditions. Participants underwent clinical, laboratory and MRI examination (semi-coronal STIR and T1W sequences) of the SIJs. MRIs were evaluated according to the SPARCC MRI definitions of lesions1 2 by two independent readers. Analyses were based on “concordant reads”, i.e. where both readers agreed on presence of the assessed pathology. In nine slices covering the entire cartilaginous compartment, each SIJ was separately assessed for the presence of FAT in relation to joint space (FAT@joint space), erosion (FAT@erosion), sclerosis (FAT@sclerosis) and ankylosis (FAT@ankylosis), respectively. Each of these “relation scores” had a total score range of 0-18 per patient.

Results: Table 1 shows the clinical characteristics of each group and table 2 shows the mean MRI FAT relation scores and the frequency of scores above various cut-off levels for each MRI relation score (concordant reads). FAT@joint space and FAT@sclerosis were seen in most groups, but higher scores were found in the axSpA group. FAT@erosion was almost only, and FAT@ankylosis exclusively, found in the axSpA group. A score above or equal to 1 (cut-off score ≥1) FAT@joint space was present in nearly all groups, however most frequent in the axSpA group followed by the group of healthy men. FAT@joint space was even present in both groups at high (≥10) cut-off scores. FAT@sclerosis was present in axSpA, women with postpartum pain and healthy men, however, at higher thresholds, above ≥2, only in axSpA group.

Conclusion: Fat lesions in relation to other structural lesions were rarely recorded in the non-axSpA groups, in contrast to fat lesions in relation to the joint space. Assessment of structural sacroiliac joint lesions in anatomical relation to each other may be useful for differentiating axSpA from other conditions.

 

Referencer:

  1. Weber et al. AR 2010;62(10):3048-58.
  2. Seven et al. annrheumdis-2018-eular.2586
  3. Maksymowych et al. AR 2005;53(5):703-9.
  4. Maksymowych et al. J Rheumatol. 2015;42(1):79-86.


ACR19_abstract_Table1_20190603

Table 1. Demographic, clinical and biochemical characteristics of the different groups of study participants


ACR19_abstract_Table2_20190603

Table 2. FAT relation scores and proportion of participants with a score above a certain level. Results based on concordant reads


Disclosure: S. Seven, None; M. Østergaard, AbbVie, 2, 8, 9, Abbvie, 2, 5, 8, Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, UCB, 5, 8, Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, and UCB, 5, 8, Abbvie, Celgene, Centocor, Merck, and Novartis, 2, Abbvie, Celgene, Centocor, Merck, Novartis, 2, BMS, 2, 5, 8, 9, Boehringer Ingelheim, 5, 8, Boehringer-Ingelheim, 2, 8, Boehringer-ingelheim, 9, Celgene, 2, 5, 8, Centocor, 2, Eli Lilly, 5, 8, 9, Eli Lilly and Company, 5, 8, Eli-Lilly, 2, 8, Hospira, 2, 5, 8, Janssen, 2, 5, 8, 9, Merck, 2, 5, 8, 9, Novartis, 2, 5, 8, Novo, 2, 5, 8, Novo Nordisk, 5, 8, Orion, 2, 5, 8, Pfizer, 2, 5, 8, 9, Regeneron, 2, 5, 8, Roche, 2, 5, 8, roche, 9, Sandoz, 2, 8, Sanofi, 2, 8, UCB, 2, 5, 8; L. Morsel-Carlsen, None; i. Sørensen, None; B. Bonde, None; G. Thamsborg, None; J. Lykkegaard, None; O. Hendricks, None; N. Jørgensen, None; S. Juhl Pedersen, None.

To cite this abstract in AMA style:

Seven S, Østergaard M, Morsel-Carlsen L, Sørensen i, Bonde B, Thamsborg G, Lykkegaard J, Hendricks O, Jørgensen N, Juhl Pedersen S. The Utility of Fat Lesions in Close Relation to Other Structural MRI Lesions in the Sacroiliac Joints for Diagnosing Patients with Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-utility-of-fat-lesions-in-close-relation-to-other-structural-mri-lesions-in-the-sacroiliac-joints-for-diagnosing-patients-with-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-utility-of-fat-lesions-in-close-relation-to-other-structural-mri-lesions-in-the-sacroiliac-joints-for-diagnosing-patients-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology